Skip to main content
Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
117.43
-0.86 (-0.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Repligen Revenue

In the year 2025, Repligen had annual revenue of $738.26M with 16.36% growth. Repligen had revenue of $197.91M in the quarter ending December 31, 2025, with 18.12% growth.

Revenue (ttm)
$738.26M
Revenue Growth
+16.36%
P/S Ratio
8.97
Revenue / Employee
$369,128
Employees
2,000
Market Cap
6.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025738.26M103.82M16.36%
Dec 31, 2024634.44M2.08M0.33%
Dec 31, 2023632.36M-169.17M-21.11%
Dec 31, 2022801.54M131.00M19.54%
Dec 31, 2021670.53M304.27M83.08%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Baxter International 11.24B
Solventum 8.33B
Avantor 6.55B
Bausch + Lomb 5.10B
The Cooper Companies 4.15B
AptarGroup 3.78B
MiniMed Group 2.99B
Envista Holdings 2.72B
Revenue Rankings

RGEN News

More News